Addition of Cetuximab to Chemoradiation in Esophageal Cancer Does Not Improve OS
Published: | Updated:
Adding cetuximab to concurrent chemoradiotherapy did not improve overall survival in patients with adenocarcinoma or squamous cell carcinoma of the esophagus.
